首页 › 基金 › Stonegate Management LLC › ABT
Stonegate Management LLC 对 ABT 的持仓历史
ABBOTT LABORATORIES · 医疗保健
Stonegate Management LLC 在 Q3 2025 的 13F 申报中披露持有 ABT(ABBOTT LABORATORIES)3,400 股,市值约 US$455K,约占其申报组合的 0.30%,在其申报持仓中市值排名第 50 位。 Stonegate Management LLC 于 Q3 2025 首次申报该持仓。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
Stonegate Management LLC 对 ABT 的持仓演变
Stonegate Management LLC 于 Q3 2025 首次披露 ABT 持仓:3,400 股(约 US$455K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 3.40K | $455.40K | 新进 |
关于 ABT 与 13F 数据
ABT(ABBOTT LABORATORIES)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 ABT,申报仓位最大的包括:先锋集团 (US$22.00B), 嘉信理财投资管理 (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABT 的基金
- 先锋集团 175.56M 股 · $22.00B · Q4 2025
- 嘉信理财投资管理 59.67M 股 · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M 股 · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M 股 · $5.41B · Q2 2026
- 资本研究全球投资者 36.91M 股 · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M 股 · $3.35B · Q2 2026
- Capital International Investors 34.65M 股 · $3.15B · Q2 2026
- 德意志银行 16.71M 股 · $1.52B · Q2 2026
更多关于 Stonegate Management LLC
常见问题
How long has Stonegate Management LLC held ABT?
Stonegate Management LLC has disclosed ABT holdings in 1 of the last 1 reported quarters, going back to Q3 2025.
What is Stonegate Management LLC's current position in ABT?
As of Q3 2025, Stonegate Management LLC holds 3.40K shares of ABT (ABBOTT LABORATORIES), valued at $455.40K, representing 0.30% of its reported portfolio and ranking #50.
Has Stonegate Management LLC been buying or selling ABT?
In the latest 13F filing (Q3 2025), Stonegate Management LLC newly opened its position in ABT.
Which other funds hold ABT?
Other major institutional holders of ABT include 先锋集团, 嘉信理财投资管理, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.